Cadence Pharmaceuticals, Inc. (NASDAQ:CADX)
CAPS Rating:
A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.
A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.
Recs
any upside to be realized may not be in the near future as sales can not be taken for granted